Jos A. Stigt

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2024 · 182 citations · Full text

Medicine, Oncology, Pharmacology +9

Pulmonary function in Parkinson's disease.

A. Hovestadt, J. M. Bogaard, J. D. Meerwaldt et al. · Journal of Neurology Neurosurgery & Psychiatry · 1989 · 151 citations · Full text

Medicine, Clinical Sciences, Neurology +17

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non–Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study

Dirk De Ruysscher, Anne‐Marie C. Dingemans, J. Praag et al. · Journal of Clinical Oncology · 2018 · 121 citations · Full text

Medicine, Oncology, Surgery +17

A Randomized Controlled Trial of Postthoracotomy Pulmonary Rehabilitation in Patients with Resectable Lung Cancer

Jos A. Stigt, Steven Uil, Susanne J.H. van Riesen et al. · Journal of Thoracic Oncology · 2012 · 109 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +17

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Bonne Biesma, A.N.M. Wymenga, Andrew Vincent et al. · Annals of Oncology · 2011 · 101 citations

Medicine, Geriatric Medicine, Oncology +17